Form 4 for IRD Opus Genetics, Inc.
Accepted 2024-01-03 00:00:00 ET · period of report 2024-01-01 · accession 0001140361-24-000494 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-03 | 2024-01-01 | IRD | Rodgers Richard J | Dir | A - Grant | — | +24.8K | 198.0K | +14% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-01 | A | A | 24,762 | — | 198,008 | D | — | — | (F1) The Reporting Person was granted shares of common stock in lieu of cash for board services for 2024. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock for the 30 consecutive trading days ending on and including the last trading day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $2.81 per share, the average of the closing price of the common stock for the 30 consecutive trading days prior to January 1, 2024. |